Live from the NIH registry
Studies recruiting near Palm Bay right now
Top 25 of 73 recruiting studies, sorted by proximity — each links to its official registry page
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Limited Stage Small Cell Lung Cancer
Phase 2
Interventional 250 participants sought
Cancer Care Centers of Brevard — Palm Bay, Florida (6.5 mi)
· Sponsor: SCRI Development Innovations, LLC
A Prospective Registry of Vaginal Photobiomodulation for Chronic Pelvic Pain.
Chronic Pelvic Pain
N/A
Observational 1,000 participants sought
Zipper Urogynecology Associates — Melbourne, Florida (8.9 mi)
· Sponsor: SoLa Pelvic Therapy
A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
Alzheimer Disease
Phase 4
Interventional 150 participants sought
Clincloud, LLC - Viera Office — Melbourne, Florida (8.9 mi)
· Sponsor: Alpha Cognition, Inc
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer, c-MET
Phase 2, Phase 3
Interventional 490 participants sought
Cancer Care Centers of Brevard- Rockledge /ID# 277853 — Rockledge, Florida (27.1 mi)
· Sponsor: AbbVie
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Urothelial Carcinoma
Phase 2
Interventional 372 participants sought
Florida Cancer Specialists — Vero Beach, Florida (27.6 mi)
· Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung Cancer
Phase 3
Interventional 590 participants sought
Cancer Care Centers of Breevard — Rockledge, Florida (27.1 mi)
· Sponsor: Revolution Medicines, Inc.
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
NASH With Fibrosis, MASH With Fibrosis
Phase 3
Interventional 1,650 participants sought
Akero Clinical Study Site — Viera, Florida (20.2 mi)
· Sponsor: Akero Therapeutics, Inc
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
Non-Small Cell Lung Cancer
Phase 3
Interventional 1,600 participants sought
Cancer Care of Brevard — Palm Bay, Florida (6.5 mi)
· Sponsor: Summit Therapeutics
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis, Non-alcoholic Fatty Liver Disease
Phase 2
Interventional 42 participants sought
GSK Investigational Site — Viera, Florida (20.2 mi)
· Sponsor: GlaxoSmithKline
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
Osteoarthritis, Knee, Diabetic Neuropathic Pain
Phase 2
Interventional 10,000 participants sought
Merritt Island Medical Research, LLC — Merritt Island, Florida (27.4 mi)
· Sponsor: Eli Lilly and Company
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
Metabolic Dysfunction-associated Steatohepatitis
Phase 2
Interventional 160 participants sought
ClinCloud, LLC — Viera, Florida (20.2 mi)
· Sponsor: Eccogene
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
Chronic Kidney Disease
Phase 3
Interventional 7,000 participants sought
Research Site — Melbourne, Florida (8.9 mi)
· Sponsor: AstraZeneca
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
Major Depressive Disorder (MDD), Major Depressive Disorder With Anxious Distress
Phase 2
Interventional 360 participants sought
Seaport Investigator Site — Palm Bay, Florida (6.5 mi)
· Sponsor: Seaport Therapeutics
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain
Diabetic Peripheral Neuropathic Pain
Phase 2
Interventional 150 participants sought
Merritt Island Medical Research, LLC — Merritt Island, Florida (27.4 mi)
· Sponsor: Eli Lilly and Company
A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
Type II Diabetes Mellitus
Phase 2
Interventional 240 participants sought
AES - DRS - Optimal Research Florida - Melbourne — Melbourne, Florida (8.9 mi)
· Sponsor: Corxel Pharmaceuticals
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
Early Alzheimer's Disease
Phase 2
Interventional 340 participants sought
ClinCloud LLC ( Site 1039) — Melbourne, Florida (8.9 mi)
· Sponsor: Merck Sharp & Dohme LLC
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
Cancer Care Centers of Brevard, Inc — Palm Bay, Florida (6.5 mi)
· Sponsor: Relay Therapeutics, Inc.
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
Diabetic Peripheral Neuropathic Pain
Phase 3
Interventional 734 participants sought
ClinCloud - Viera — Viera, Florida (20.2 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
Carcinoma, Non-Small-Cell Lung
Phase 3
Interventional 630 participants sought
Cancer Care Centers of Brevard, Inc. — Palm Bay, Florida (6.5 mi)
· Sponsor: Mirati Therapeutics Inc.
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)
Psychosis Associated With Alzheimer's Disease
Phase 3
Interventional 500 participants sought
Local Institution - 1131 — Viera, Florida (20.2 mi)
· Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
[18F]PI-2620 Phase 3 Histopathological Study
Alzheimer Disease
Phase 3
Interventional 200 participants sought
ClinCloud Research — Melbourne, Florida (8.9 mi)
· Sponsor: Lantheus Biosciences Ltd.
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Kidney Disease
Phase 3
Interventional 347 participants sought
Panoramic Health - Florida Kidney Physicians, LLC (Melbourne) — Melbourne, Florida (8.9 mi)
· Sponsor: Takeda
FastWire REvascularisation of Extremities, (For LOWer Limbs) - FREEFLOW
Chronic Total Occlusion of Artery of the Extremities
N/A
Interventional 65 participants sought
Vascular & Embolization Specialists — Cocoa, Florida (29.7 mi)
· Sponsor: Versono Medical Ltd
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma
Phase 2, Phase 3
Interventional 650 participants sought
Site #0136 — Palm Bay, Florida (6.5 mi)
· Sponsor: Bicara Therapeutics
Clinical Trial on Agitation in Alzheimer's Dementia
Alzheimer Disease, Agitation,Psychomotor
Phase 2
Interventional 164 participants sought
ClinCloud, LLC — Melbourne, Florida (8.9 mi)
· Sponsor: IGC Pharma, LLC